AVR 4.53% $15.68 anteris technologies ltd

News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-546

  1. 1,535 Posts.
    lightbulb Created with Sketch. 303
    I can see this product being accepted in Europe hopefully they are not like the US . The health insurance companies have a lot to do with what products are used over in the US . I had a American friend who got luekimia and his insurance company would only pay for a particular type of Chemo even though there were much better products on the market which offered him a better chance of survival .My friend did the research a pulled the extra money out of his own pocket to fund the better Chemo drug . Problem is how many don’t do the research about the Edwards product and it’s longivity . Long term I think the US will come around or Edwards will buy out AHZ and use their technology
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$15.68
Change
0.680(4.53%)
Mkt cap ! $331.4M
Open High Low Value Volume
$14.90 $15.75 $14.85 $431.9K 28.2K

Buyers (Bids)

No. Vol. Price($)
1 200 $15.21
 

Sellers (Offers)

Price($) Vol. No.
$15.95 300 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.